在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human Erythropoietin,EPO ELISA Kit

  • 中文名稱:
    人紅細(xì)胞生成素(EPO)酶聯(lián)免疫試劑盒
  • 貨號(hào):
    CSB-E04538h
  • 規(guī)格:
    96T/48T
  • 價(jià)格:
    ¥3600/¥2500
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品描述:
    人紅細(xì)胞生成素(EPO)酶聯(lián)免疫試劑盒(CSB-E04538h)為雙抗夾心法ELISA試劑盒,定量檢測(cè)樣本中的EPO含量。EPO即促紅細(xì)胞生成素,其產(chǎn)生于腎臟,能促進(jìn)紅細(xì)胞生成、提高氧氣運(yùn)輸能力。在研究機(jī)制上,它作用于骨髓中紅系祖細(xì)胞表面受體,刺激其增殖、分化和成熟。了解這一靶點(diǎn)對(duì)治療貧血等紅細(xì)胞相關(guān)疾病有重要意義。該產(chǎn)品適用于科研領(lǐng)域中對(duì)EPO表達(dá)調(diào)控的基礎(chǔ)研究、貧血相關(guān)疾病模型的分子機(jī)制探索,以及藥物或生物制劑對(duì)紅細(xì)胞生成影響的體外評(píng)估實(shí)驗(yàn),為生命科學(xué)研究和生物標(biāo)志物開發(fā)提供可靠工具。本品僅用于科研,不用于臨床診斷,產(chǎn)品具體參數(shù)及操作步驟詳見產(chǎn)品說明書。
  • 別名:
    EPOErythropoietin ELISA kit; Epoetin ELISA kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測(cè)范圍:
    0.78 mIU/ml-50 mIU/ml
  • 靈敏度:
    0.195 mIU/ml
  • 反應(yīng)時(shí)間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測(cè)波長(zhǎng):
    450 nm
  • 研究領(lǐng)域:
    Immunology
  • 測(cè)定原理:
    quantitative
  • 測(cè)定方法:
    Sandwich
  • 數(shù)據(jù)處理:
  • 貨期:
    3-5 working days

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

  • 功能:
    Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3.
  • 基因功能參考文獻(xiàn):
    1. Increases in plasma erythropoietin and erythropoietin receptor activation are mechanisms implicated in the increase of plasma FGF23 in acute kidney injury. PMID: 29395333
    2. the implication of alpha-7-nAChR-JAK-2/STAT-3-Nrf-2 signaling cascade in the radiomitigative potential of EPO against ARS PMID: 29220591
    3. Pro-inflammatory proteins S100A9 and tumor necrosis factor-alpha suppress erythropoietin elaboration in myelodysplastic syndromes PMID: 28983059
    4. EPO levels in the coronary artery disease (CAD) group were higher than those in the non-CAD group. The correlation between red cell distribution width and EPO levels was statistically significant among CAD patients. PMID: 28885393
    5. CD133(+) cells contributed to the local production of erythropoietin, as observed by detection of circulating human erythropoietin. CD133(+) cells appear therefore an effective source for cell repair, able to restore renal functions, including erythropoietin release, and to limit long term maldifferentiation and fibrosis. PMID: 27853265
    6. Circulating anti-EPO are detected in a significant proportion of treatment-naive HCV-infected patients and are independently associated with anemia, suggesting a further implication of autoimmunity in the pathophysiology of HCV-related anemia. PMID: 28603097
    7. the T allele of SNP rs60684937 located at 67,419,130 bp on chromosome 17 was associated with increased plasma EPO and a relatively increased expression of a non-coding transcript of PRKAR1A in sickle cell disease patients PMID: 28173069
    8. study describes a gain-of-function variant in EPO in an extended kindred with familial erythrocytosis, including 10 affected family members in four generations; this mutation, a single-nucleotide deletion (c.32delG), introduces a frameshift in exon 2 PMID: 29514032
    9. Here, using zebrafish, murine, and human models, the authors show that erythropoietin (EPO) signaling, together with the GATA1 transcriptional target, AKAP10, regulates heme biosynthesis during erythropoiesis at the outer mitochondrial membrane. PMID: 28553927
    10. Reduction in central venous blood pressure prompts an increase in plasma EPO concentration independent of hemoconcentration and hence suggests CVP per se as an acute regulator of EPO synthesis PMID: 27169519
    11. EPO (7q22) and SEC-61(7p11) emerged as new candidate genes susceptible to genetic losses with 57.7% deletions identified in regions on chromosome 7. PMID: 27282568
    12. The current controversy may derive from a context-dependent mode of action of Epo, namely opposite skeletal actions during bone regeneration and steady-state bone remodeling. PMID: 26822707
    13. High EPO expression is associated with monoclonal gammopathy of undetermined significance and multiple myeloma. PMID: 26919105
    14. age 3 plasma levels of EPO were found related to childhood asthma PMID: 27434124
    15. EPO induces an EMT-like process in mammary non-tumorigenic epithelial cells PMID: 28247960
    16. these results suggested that quercetin's cytoprotective effects in HepG2 cells are mediated via EPO production. PMID: 29080630
    17. Serum Epo and VEGF may be markers of severity of hypoxia-ischaemia and brain injury as they are closely related to hypoxic exposure. PMID: 27902983
    18. CIS interacted with phosphorylated EpoR at Y401, which was critical for the activation of STAT5 and ERK. PMID: 28038963
    19. EPO dependent regulation pathway of FGF23 gene expression PMID: 29073196
    20. Fetal plasma EPO concentrations are selectively increased in monochorionic twin pregnancies with intrauterine growth restriction. PMID: 27161360
    21. this study shows that EPO is involved in the pathogenesis of sepsis-induced acute kidney injury PMID: 27266727
    22. Erythropoietin is superior to the standard prognostic scores in predicting 28-day mortality in patients with acute-on-chronic liver failure. PMID: 27981303
    23. EPO levels were also found correlated positively with heme, TNF-alpha, IL-10, IP-10 and MCP-1 during cerebral malaria. PMID: 27441662
    24. Three single nucleotide polymorphisms are associated with increased risk of diabetic retinopathy in a Chinese Han population. PMID: 27190272
    25. Pharmacokinetic animal studies revealed strongly 15.6-fold plasma half-life extension for the PASylated EPO (83.16 +/- 13.28 h) in comparison to epoetin alpha (8.5 +/- 2.4 h) and darbepoetin alpha (25.3 +/- 2.2h). PMID: 28168382
    26. Secreted MIR122 reached the kidney and reduced expression of erythropoietin, contributing to inflammation-induced anemia. PMID: 27477940
    27. this paper shows that Epo could directly down-regulate pro-inflammatory T cell responses without affecting T cell activation status PMID: 27208431
    28. findings suggest that erythropoietin levels in anemia of unknown etiology, although elevated, remain inappropriately low, particularly when compared with other forms of anemia. This suggests a relative erythropoietin deficiency or a blunted erythroid cell response. PMID: 26747131
    29. Plasma IGFBP-1 was significantly associated with plasma EPO concentration in acute kidney injury, suggesting an unknown mechanism related to systemic stress conditions for EPO regulation in AKI. PMID: 26479890
    30. Our results suggest that EPO/EPOR pathway promotes gastric cancer formation, proliferation, migration, and decreases apoptosis PMID: 27086036
    31. These results suggest that both EpoR-positive and EpoR-negative cancer cells could be regulated by exogenous Epo. However, an increased response to erythropoietin was observed in the EpoR-positive cells. Thus, erythropoietin increases the risk of tumor progression in colon cancer and should not be used to treat anemia in this type of cancer. PMID: 27543111
    32. Overexpression of EPO is associated with clear cell renal cell carcinoma. PMID: 27468719
    33. EPO may play an important role in stem cell mobilization through up regulating HGF in mesenchymal stem cells and inducing migration of hematopoietic stem/progenitor cells PMID: 27865586
    34. A review of contemporary aspects of EPO relating to chronic liver disease. [review] PMID: 26919118
    35. Hepatic EPO synthesis is not enhanced in cirrhosis. PMID: 26924722
    36. Conclusion: Anemia in cancers was not because of inadequate Epo or Fe levels, but because of improper Epo response. PMID: 26838000
    37. In multivariate survival analysis, age, Epo and EpoR were independent prognostic factors related to overall survival in hepatocellular carcinoma. PMID: 26097591
    38. Suggest that hypoxia prevents EPO suppression, and exaggerates the plasma volume reduction induced by bed rest. PMID: 27081163
    39. Inadequate erythropoietin response may partly explain anemia in anorexia nervosa. PMID: 26049959
    40. these findings suggest that TGF-beta suppression and EPO stimulation promote erythropoiesis of CD34(+)CD31(+) progenitor cells derived from hPSCs. PMID: 26012423
    41. Our findings have important potential clinical implications, indicating that EPO supplementation in rhabdomyosarcoma patients may have the unwanted side effect of tumor progression. PMID: 26412593
    42. suggest that rhEPO regulates apoptosis-related genes and affects apoptosis in the hippocampus of aging rats by upregulating SIRT. PMID: 26261574
    43. Higher levels of endogenous erythropoietin are associated with incident heart failure in older adults. PMID: 26721912
    44. Erythropoietin protects mouse renal tubular basement membrane by promoting bone marrow cells to generate and secrete miR-144, which, in turn, inhibits activation of the tPA/MMP9-mediated proteolytic network. PMID: 26469975
    45. The review describes the induction of erythropoietin gene expression in liver, reproouctive and hemopoietic systems during hypoxia or a state of proliferation. PMID: 26995951
    46. Our data suggest that rs507392 and rs551238 in the erythropoietin gene probably act to lessen the risk for diabetic retinopathy (DR) in a Chinese cohort with type 2 diabetes mellitus (T2DM). PMID: 25675872
    47. Data suggest maternal circulating 25-hydroxyvitamin D during mid-pregnancy and at delivery is inversely related to serum EPO; an indirect relation observed between circulating vitamin D and circulating hemoglobin is at least partly mediated by EPO. PMID: 26447159
    48. This review gleans these different strategies and highlights the leading molecular recognition elements that have potential roles in rHuEPO doping detection. PMID: 25058943
    49. The addition of salt (even low concentrations of the strong chaotrope salt guanidinium hydrochloride) also exponentially decreased the initial rate of soluble erythropoietin non-native aggregation at 37 degrees C storage PMID: 25628168
    50. In very preterm infants, whether elevated perinatal erythropoietin (EPO) concentrations are associated with increased risks of indicators of brain damage, was determined. PMID: 25793991

    顯示更多

    收起更多

  • 相關(guān)疾病:
    Microvascular complications of diabetes 2 (MVCD2)
  • 亞細(xì)胞定位:
    Secreted.
  • 蛋白家族:
    EPO/TPO family
  • 組織特異性:
    Produced by kidney or liver of adult mammals and by liver of fetal or neonatal mammals.
  • 數(shù)據(jù)庫(kù)鏈接:

    HGNC: 3415

    OMIM: 133170

    KEGG: hsa:2056

    STRING: 9606.ENSP00000252723

    UniGene: Hs.2303



主站蜘蛛池模板: 久久国产精品福利一区二区三区| 国产无套粉嫩白浆在线观看| 日本免费一区二区三区视频观看| 一区二区三区视频| 一区二区无码免费视频网站| 看国产一毛片在线看手机看| 中国美女牲交视频| 久久久久人妻一区精品果冻 | 麻豆av一区二区三区久久| 狠狠色综合久久丁香婷婷| 日本熟妇色xxxxx欧美老妇| 14萝自慰专用网站| 亚洲国产av高清无码| 人人妻人人澡人人爽欧美一区九九 | 日本久久久久久久做爰片日本| 午夜成人无码片在线观看影院| 免费无码av片流白浆在线观看| 欧美性猛交ⅹxxx乱大交妖精| 天天综合天天爱天天做| 国产尤物人成免费观看| 国产成人欧美一区二区三区| 国产欧美一区二区三区在线看| 亚洲中文字幕无码mv| 欧美孕妇xxxx做受欧美88| 国产欧美va天堂在线观看视频| 老司机亚洲精品影院| 婷婷五月俺也去人妻| 无码专区6080yy国产电影| 美女无遮挡免费视频网站| 国产麻豆乱子伦午夜视频观看| 精品无码一区在线观看| 国产精品自在拍在线拍| 国产精品爆乳在线播放第一人称| 日本在线a一区视频| 亚洲第一福利网站在线观看| 邻居少妇张开双腿让我爽一夜| 3344永久在线观看视频| 亚洲国产欧美中文丝袜日韩| 亚洲日韩aⅴ在线视频| 亚洲人成在线观看网站不卡 | 亚洲成av人最新无码|